A meta-analysis of markers of central inflammation in MDD patients determined CSF levels of IL-6 and TNF-α were higher in MDD patients compared to controls, and there was no significant correlation between abnormalities in CSF and those seen in peripheral blood (Enache et al., 2019), further complicating understanding the mechanisms underlying these conditions and how pharmacological agents may interact. Here, IL6 is linked to major depressive disorder.